These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12973000)

  • 21. Pericardial Solitary Fibrous Tumor on FDG PET/CT.
    Shao D; Wang SX
    Clin Nucl Med; 2019 Jan; 44(1):85-87. PubMed ID: 30371588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
    Lowe VJ; Wiseman GA
    J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of FDG positron emission tomography imaging on the management of lymphomas.
    Shah N; Hoskin P; McMillan A; Gibson P; Lowe J; wong WL
    Br J Radiol; 2000 May; 73(869):482-7. PubMed ID: 10884743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation].
    Toubai T; Ota S; Onodera M; Baba U; Fujisawa F; Miura Y; Toyoshima N; Tanaka J; Asaka M; Imamura M
    Rinsho Ketsueki; 2003 Jul; 44(7):446-50. PubMed ID: 12931562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-FDG PET/CT Finding of Primary Cardiac Lymphoma.
    Kaida H; Kumode T; Kimura M; Ishii K
    Clin Nucl Med; 2020 Apr; 45(4):319-321. PubMed ID: 32049734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
    Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
    Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
    [No Abstract]   [Full Text] [Related]  

  • 27. Whole body positron emission tomography in the treatment of Hodgkin disease.
    Hueltenschmidt B; Sautter-Bihl ML; Lang O; Maul FD; Fischer J; Mergenthaler HG; Bihl H
    Cancer; 2001 Jan; 91(2):302-10. PubMed ID: 11180075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of metastatic involvement of the pericardium on F-18 FDG-PET/CT imaging.
    Douroukas A; Arena V; Pelosi E
    Clin Nucl Med; 2009 Jan; 34(1):40-1. PubMed ID: 19092385
    [No Abstract]   [Full Text] [Related]  

  • 29. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
    Hernandez-Maraver D; Hernandez-Navarro F; Gomez-Leon N; Coya J; Rodriguez-Vigil B; Madero R; Pinilla I; Martin-Curto LM
    Br J Haematol; 2006 Nov; 135(3):293-302. PubMed ID: 17032175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
    Spaepen K; Mortelmans L
    Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
    Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
    Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P; Sica S; Leone G
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG positron emission tomography in lymphoma.
    Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
    [No Abstract]   [Full Text] [Related]  

  • 39. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.
    Ost P; Rottey S; Smeets P; Boterberg T; Stragier B; Goethals I
    J Thorac Imaging; 2008 Feb; 23(1):35-8. PubMed ID: 18347518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.